A Study to Test CRT-402 in Refractory Autoimmune Disease

Clinical trial NCT07778446 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07778446
Sponsor: Myeloid Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Autoimmune Diseases Systemic Lupus Erythematosus Systemic Scleroderma Myositis

Start date: 2026-08-24
Primary completion: 2028-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.